Evidence map›Paper›PMID 40659556›Full record

ArticleJournal of microbiology and biotechnology2025

Yan Liu, Yuzhu Shi, Lei Xu, Xue Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan LiuXinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica, Urumqi 830004, P.R. China.
Yuzhu ShiXinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica, Urumqi 830004, P.R. China.
Lei XuXinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica, Urumqi 830004, P.R. China.
Xue WangXinjiang Key Laboratory for Uighur Medicine, Xinjiang Institute of Materia Medica, Urumqi 830004, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury (ALI) is a prevalent critical respiratory disease associated with high morbidity and mortality rates.

Indexed as

Acute Lung InjuryInflammasomesNF-E2-Related Factor 2NLR Family, Pyrin Domain-Containing 3 ProteinPlant ExtractsSignal TransductionViolaAnimalsAnti-Inflammatory AgentsCytokinesDisease Models, AnimalLipopolysaccharidesLungMaleMiceMice, Inbred C57BLAnti-Inflammatory AgentsCytokinesInflammasomesLipopolysaccharidesNfe2l2 protein, mouseNF-E2-Related Factor 2NLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePlant Extractsacute lung injurylipopolysaccharideNLRP3 inflammasomeNrf2 signaling pathwayViola tianshanica maxim extract

Identifiers

PMID40659556
PMCPMC12289466

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.